Sanofi (SNY) Exchange Rate Effect (2013 - 2026)
Sanofi (SNY) posted Exchange Rate Effect of $11.6 million for Q2 2026, up 10.32% sequentially from $10.5 million in Q1 2026, and up 146.68% YoY from $4.7 million in Q2 2025.
Sanofi (SNY) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Sanofi has reported Exchange Rate Effect for 11 years, with the latest figure at $11.6 million in Q2 2026.
- Quarterly Exchange Rate Effect rose 146.68% year-over-year to $11.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$95.7 million (down 39.78% YoY) and the FY2025 annual result came in at -$54.7 million, down 293.83% from the prior year.
- Exchange Rate Effect advanced to $11.6 million in Q2 2026 per SNY's latest filing, from $10.5 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $11.6 million in Q2 2026 and troughed at -$63.1 million in Q3 2025.
- A 3-year average of -$18.8 million and a median of -$13.9 million in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect plunged 293.83% in 2025, then surged 150.08% in 2026.
- Over 3 years, Exchange Rate Effect stood at -$13.9 million in 2024, then slumped by 293.83% to -$54.7 million in 2025, then jumped by 121.25% to $11.6 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $11.6 million, $10.5 million, and -$54.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.32 Bn | 632.56 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 470.11 Bn | 463.54 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 376.14 Bn | 369.00 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 303.26 Bn | 295.57 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 257.39 Bn | 252.49 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 236.59 Bn | 222.60 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.91 Bn | 178.73 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 159.26 Bn | 147.57 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 106.16 Bn | 101.99 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.11 Bn | 47.73 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.62 Mn |
| Jun 30, 2026 | 11.62 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | -54.71 Mn |
| Dec 31, 2025 | -54.71 Mn |
| Sep 30, 2025 | -63.13 Mn |
| Sep 30, 2025 | -63.13 Mn |
| Jun 30, 2025 | -24.90 Mn |
| Jun 30, 2025 | -24.90 Mn |
| Mar 31, 2025 | -21.04 Mn |
| Mar 31, 2025 | -21.04 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Jun 30, 2024 | -8.62 Mn |
| Jun 30, 2024 | -8.62 Mn |
| Mar 31, 2024 | -5.43 Mn |
| Mar 31, 2024 | -5.43 Mn |
| Dec 31, 2021 | 11.78 Mn |
| Dec 31, 2021 | 11.78 Mn |